Jiangsu Hengrui Pharmaceuticals (01276) spent 3.1936 million yuan to repurchase 70,000 A-shares on June 9.
Hengrui Medicine (01276) announced that on June 9, 2026, the company will spend RMB 3,193,600 to repurchase 70,000 A-shares at a repurchase price of RMB 45.3-45.82 per share.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on June 9, 2026, the company spent RMB 3.1936 million to repurchase 70,000 A-shares at a repurchase price of RMB 45.3-45.82 per share.
Related Articles
LONGFOR GROUP (00960) achieved a total contract sales amount of 13.67 billion RMB in the first five months.
On June 9th, Haier SmartHome (06690) spent approximately 23.23 million yuan to repurchase 1.2078 million A-shares.
On June 9th, DMALL (02586) spent 6.7686 million Hong Kong dollars to repurchase 1.1482 million shares.
LONGFOR GROUP (00960) achieved a total contract sales amount of 13.67 billion RMB in the first five months.
On June 9th, Haier SmartHome (06690) spent approximately 23.23 million yuan to repurchase 1.2078 million A-shares.
On June 9th, DMALL (02586) spent 6.7686 million Hong Kong dollars to repurchase 1.1482 million shares.
